1. Moreira POL, Nogueira PM, Monte-Neto RL. Next-Generation Leishmanization: Revisiting Molecular Targets for Selecting Genetically Engineered Live-Attenuated Leishmania. Microorganisms. 2023; 11: 1043.
2. Mohebali M, Nadim A, Khamesipour A. An overview of leishmanization experience: A successful control measure and a tool to evaluate candidate vaccines. Acta Trop. 2019; 200:105173. doi: 10.1016/j.actatropica.2019; 105173.
3. Kazemi B, Tahvidar- Bideroni Gh, Hashemi Feshareki R, Javadian E. Isolation a lizard Leishmania promastigote from natural host in Iran. J Biol Sci. 2004; 4(5): 620-623.
4. Donyavi T, Bandehpour M, Kazemi B. Preparation of transgenic Iranian lizard Leishmania coding HIL-12 .Iran J Microbiol. 2017; 9(5): 305–311.
5. Mirzaahmadi S, Asaadi -Tehrani G, Bandehpour M, et al. Expression of recombinant human coagulation factor VII by the Lizard Leishmania expression system. J Biomed Biotechnol. 2011; 2011: 873874.
6. Jalali A, Bandehpour M, Chegeni, R, et al . Expression, Purification, and Evaluation of Anti-IL-2Rα Antibody Secreted by Leishmania tarentolae. Int J Pept Res Ther. 2021; 27(1): 301–307.
7. Taromchi AH, Kazemi B, Mahmazi S, Bandehpour M. Heterologous Expression of Human IL-29 (IFN-λ1) in Iranian Lizard Leishmania. Iran J Biotechnol. 2013; 11(3): 168-174.
8. Yadegari Z, Bandehpour M, Kazemi B, Sharifi-Sarasiabi Kh. Expression of Recombinant Human Amelogenin in Iranian Lizard Leishmania and Its Biological Function Assay. Iran J Public Health. 2015; 44(7): 987-996.
9. Ivens AC, Peacock CS, Worthey EA, et al. The genome of the kinetoplastid parasite, Leishmania major. Science. 2005; 309 (5733): 436-42.
10. Peacock CS, Seeger K, Harris D, MurphyL, Ruiz JC, Quail MA. Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet. 2007; 39 (7): 839-47.
11. McDonagh PD, Peter J. Myler PJ, Stuart K. The unusual gene organization of Leishmania major chromosome 1 may reflect novel transcription processes. Nucleic Acids Res. 2000; 28(14): 2800–3.
12. Myler PJ, Audleman L, deVos T, et al. Leishmania major Friedlin chromosome 1 has an unusual distribution of protein-coding genes. Proc Natl Acad Sci U S A. 1999; 96(6): 2902-6.
13. Myler PJ, Sisk E. McDonagh PD, et al. Genomic org-anization and gene function in Leishmania. Bioche Soc Trans. 2000; 28(5): 527– 31.
14. Myler PJ, Beverley SM, Cruz AK, et al. The Leishmania genome project: new insights into gene organization and function. Med Microbiol Immunol. 2001; 190 (1-2): 9-12.
15. Gentil LG, Lasakosvitsch F, Silveira JF, Santos MR, Barbiéri CL. Analysis and chromosomal mapping of Leishmania (Leishmania) amazonensis amastigote expressed sequence tags. Mem Inst Oswaldo Cruz. 2007; 102(6): 707-11.
16. Fong D, Lee B. Beta tubulin gene of the parasitic protozoan Leishmania mexicana. Mol Biochem Parasitol. 1988; 31(1): 97-106.
17. Hejazi SH, Zia-Jahromi N, Bandehpour M, et al. Gene Cloning of Iranian Leishmania major Mannose-1-Phosphate Guanyltransferase. Iran J Parasitol. 2009; 4(3): 1-9.
18. Kheirandish F, Bandehpour M, Haghighi A, Mohebali M, Mahboudi F, Kazemi B. Molecular cloning, Expression and Enzymatic assay of Iranian Leishmania major pteridine reductase 1. Iran J Parasitol. 2008; 3 (2): 1-9.
19. Rasouli M, Zavaran Hoseini A, Kazemi B, Alborzi A, Kiany S. Expression of heat shock protein 70 of MCAN/IT/96/LON-49, a tool for diagnosis and future vaccine research. Iran J Immunol. 2009; 6(2): 75-86.
20. Kazemi B, Tohidi F, Bandehpour M, Yarian F. Molecular Cloning, Expression, and Enzymatic Assay of Pteridine Reductase 1 from Iranian Lizard Leishmania. Iran Biomed J. 2010; 14(3): 97-102.
21. Shaddel M, Oormazdi H, Akhlaghi L, Kazemi B, BandehpourM. Cloning of Leishmania major P4 Gene. Yahkhteh Medical Journal. 2008; 10(3): 201-4.
22. Lee MG, Van der Ploeg LH. Transcription of protein- coding genes in trypanosomes by RNA polymerase I. Annu Rev Microbiol. 1997; 51: 463-89.
23. Worthey EA, Martinez-Calvillo S, Schnaufer A, et al. Leishmania major chromosome 3 contains two long convergent polycistronic gene clusters separated by a tRNA gene. Nucleic Acids Res. 2003; 31(14): 4201–10.
24. Flinn HM, Smith DF. Genomic organization and expression of a differentially regulated gene family from Leishmania major. Nucleic Acids Res.1992; 20(4): 755-62.
25. Ma Y, Lee CJ, Park JS. Strategies for Optimizing the Production of Proteins and Peptides with Multiple Disulfide Bonds. Antibiotics (Basel). 2020; 9(9):541. doi:10.3390/antibiotics9090541
26. Rosano GL, Ceccarelli EA. Recombinant protein expression in Escherichia coli: advances and challenges. Front Microbiol. 2014; 5:172. | https://doi.org/10.3389/fmicb.2014.00172
27. Rosenzweig D, Smith D, Myler PJ, Olafson RW, Zilberstein D. Posttranslational modification of cellular proteins during Leishmania donovani differentiation. Proteomics. 2008; 8(9): 1843-50.
28. Hem S, Gherardini PF, Osorio y Fortéa J, et al. Identification of Leishmania-specific protein phosphorylation sites by LCESI- MS/MS and comparative genomics analyses. Proteomics. 2010; 10(21):3868-83.
29. Kaur J, Sundar S, Singh N. Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani. J Antimicrob Chemother. 2010; 65(8):1742-8.
30. Kumar P, Kumar A, Verma SS, et al. Leishmania donovani pteridine reductase 1: biochemical properties and structure-modeling studies. Exp Parasitol. 2008; 120(1):73-9.
31. Basile G, PeticcaM. Recombinant protein expression in Leishmania tarentolae. Mol Biotechnol. 2009; 43(3):273- 8.
32. Soleimani M, Mahboudi F, Davoudi N, et al. Expression of human tissue plasminogen activator in the trypanosomatid protozoan Leishmania tarentolae. Biotechnol Appl Biochem. 2007; 48(Pt 1): 55-61.
33. Hemayatkar M, Mahboudi F, Majidzadeh A K, et al. Increased expression of recombinant human tissue plasminogen activator in Leishmania tarentolae. Biotechnol J. 2010; 5(11):1198-206.
34. Dortay H, Roeber B. A highly efficient pipeline for protein expression in Leishmania tarentolae using infrared fluorescence protein as marker. Microbiol Cell Fact; 2010; 9: 29.
35. Sereno D, Lemesre JL. Axenically Cultured Amastigote Forms as an In Vitro Model for Investigation of Antileishmanial Agents. Antimicrob Agents Chemother. 1997; 41(5): 972–976.
36. Gupta S, Nishi. Visceral Leishmaniasis: Experimental models for drug discovery. Indian J Med Res. 2011; 133(1): 27-39.
37. Abdi Ghavidel A, Jajarmi V, Bandehpour M, Kazemi B. Polycistronic Expression of Multi-Subunit Complexes in the Eukaryotic Environment: A Narrative Review. Iran J Parasitol. 2022; 17(3): 286-295.
38. Abdi Ghavidel A, Aghamiri SH, Jajarmi V, Bandehpour M, Kazemi B. The Influence of Different Culture Media on the Growth and Recombinant Protein Production of Iranian Lizard Leishmania Promastigote. Iran J Parasitol. 2022; 17 (4)543-55.